首页> 美国卫生研究院文献>other >Effects of Postoperative Pain Management on Immune Function After Laparoscopic Resection of Colorectal Cancer
【2h】

Effects of Postoperative Pain Management on Immune Function After Laparoscopic Resection of Colorectal Cancer

机译:腹腔镜切除结直肠癌术后术后疼痛处理对免疫功能的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There has been a rising interest in the possible association between perioperative opioid use and postoperative outcomes in cancer patients. Continuous surgical wound infiltration with local anesthetics is a nonopioid analgesic technique that can be used as a postoperative pain management alternative to opioid-based intravenous patient-controlled analgesia (IV PCA). The aim of this study was to compare the effects of an opioid-based analgesic regimen versus a local anesthetic wound infiltration-based analgesic regimen on immune modulation and short-term cancer recurrence or metastasis in patients undergoing laparoscopic resection of colorectal cancer.Sixty patients undergoing laparoscopic resection of colorectal cancer were randomly assigned to either the opioid group or the ON-Q group. For postoperative analgesia during the first 48 hours, the opioid group (n = 30) received fentanyl via IV PCA, whereas the ON-Q group (n = 30) received continuous wound infiltration of 0.5% ropivacaine with an ON-Q pump and tramadol via IV PCA. Pethidine for the opioid group and ketorolac or propacetamol for the ON-Q group were used as rescue analgesics. Anesthesia was induced and maintained with propofol and remifentanil. The primary outcome was postoperative immune function assessed by natural killer cell cytotoxicity (NKCC) and interleukin-2. Secondary outcomes were postoperative complications, cancer recurrence, or metastasis within 1 year after surgery, and postoperative inflammatory responses measured by white blood cell count, neutrophil percentage, and C-reactive protein. Immune function and inflammatory responses were measured before surgery and 24 and 48 hours after surgery.Fifty-nine patients completed the study. In the circumstance of similar pain control efficacy between the opioid group and the ON-Q group, postoperative NKCC and interleukin-2 levels did not differ between the 2 groups. The incidence of postoperative complications and recurrence or metastasis within 1 year after surgery was comparable between the groups. Postoperative inflammatory responses were also similar between the groups.When compared with ropivacaine wound infiltration-based analgesia, fentanyl-based analgesia did not further decrease NKCC or affect short-term cancer recurrence or metastasis. Thus, a fentanyl-based analgesic regimen and a ropivacaine wound infiltration-based analgesic regimen can both be used for postoperative pain management in laparoscopic resection of colorectal cancer.
机译:人们对癌症患者围手术期使用阿片类药物与术后预后之间可能的关联性的兴趣日益浓厚。用局部麻醉药连续进行手术伤口浸润是一种非阿片类镇痛技术,可作为基于阿片类药物的静脉内患者自控镇痛(IV PCA)的术后疼痛管理替代方法。这项研究的目的是比较以阿片类药物为基础的镇痛方案与以局部麻醉药伤口浸润为基础的镇痛方案对腹腔镜切除结直肠癌患者的免疫调节和短期癌症复发或转移的影响。腹腔镜结肠直肠癌切除术被随机分配至阿片类药物组或ON-Q组。对于术后48小时内的镇痛,阿片类药物组(n = 30)通过静脉PCA接受芬太尼,而ON-Q组(n = 30)则通过ON-Q泵和曲马多连续伤口渗入0.5%罗哌卡因通过IV PCA。阿片类药物组为哌啶,ON-Q组为酮咯酸或扑热息痛用作急救镇痛药。异丙酚和瑞芬太尼诱导并维持麻醉。主要结果是通过自然杀伤细胞细胞毒性(NKCC)和白介素2评估的术后免疫功能。次要结果是手术后1年内的术后并发症,癌症复发或转移,以及通过白细胞计数,中性粒细胞百分比和C反应蛋白测量的术后炎症反应。在手术前以及手术后24和48小时测量免疫功能和炎症反应。59名患者完成了这项研究。在阿片类药物组和ON-Q组之间相似的止痛效果的情况下,两组之间的术后NKCC和白细胞介素2水平没有差异。两组之间术后并发症,复发或转移的发生率相当。两组之间的术后炎症反应也相似。与罗哌卡因伤口浸润为基础的镇痛相比,基于芬太尼的镇痛并没有进一步降低NKCC或影响短期癌症复发或转移。因此,基于芬太尼的镇痛方案和基于罗哌卡因伤口浸润的镇痛方案均可用于腹腔镜切除结直肠癌的术后疼痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号